Hypertrophy in response to obesity-induced metabolic and haemodynamic demands.Enhanced function via increased sodium and water reabsorption through SGLT1 and SGLT2, with pathophysiological mechanisms including lipid accumulation, activation of RAS and RhoA and aberrant hypoxic responses. The gene discussed is RHOA; the disease is obesity disorder.